A scoping review exploring the uptake of the human papilloma virus vaccine amongst young women in Ireland

Varisha Shahzad

doi:10.18203/2394-6040.ijcmph20252901

Authors

Varisha Shahzad Department of Public Health, Brunel University of London, Uxbridge, London, United Kingdom

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20252901

Keywords:

Human papillomavirus, Vaccination, Cervical cancer prevention, Irish women

Abstract

Human papillomavirus (HPV) is a sexually transmitted infection that can resolve spontaneously but may persist and lead to complications such as genital warts and cervical cancer. The National Cancer Registry Ireland (NCRI) reported an average of 264 new cases of invasive cervical cancer annually between 2015 and 2017, and 88 deaths per year between 2012 and 2014. Many of these could have been prevented through HPV vaccination. A scoping review was conducted to explore factors influencing HPV vaccine uptake among Irish women. The Arksey and O'Malley Framework guided the review process, and a preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart was used to map the literature selection. The search covered studies published between 2008 and 2022. Nine studies met the inclusion criteria, employing both qualitative and quantitative methods. These studies explored various perspectives, with increasing interest in recent years—six studies were published in the last seven years. Seven of the nine studies focused on adult women. This scoping review highlights the current literature on HPV vaccination in Ireland, identifies gaps in understanding vaccine uptake, and offers suggestions for future research to address these gaps.

Metrics

Metrics Loading ...

References

Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27. DOI: https://doi.org/10.1056/NEJMoa021641

De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a metaanalysis. Lancet Infect Dis. 2007;7:453-9. DOI: https://doi.org/10.1016/S1473-3099(07)70158-5

Health Service Executive. Immunisation Guidelines for Ireland. Available at: https://www.hse.ie/eng/ health/immunisation/hcpinfo/guidelines/chapter10.pdf. Accessed on 16 May 2025.

World Health Organisation. Cervical Cancer. 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed on 16 May 2025.

Centers for Disease Control and Prevention (CDC,2021). “HPV Infection”. Available at: https:// www.cdc.gov/hpv/parents/about-hpv.html. Accessed on 16 May 2025.

Gearhart P. Human Papillomavirus (HPV). Medscape. 2020. Available at: https://emedicine. medscape.com/article/219110-overview. Accessed on 16 May 2025.

National Cancer Institute. Cancer. 2022. Available at: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer. Accessed on 16 May 2025.

Kataja V, Syrjänen S, Yliskoski M, Hippelïnen M, Väyrynen M, Saarikoski S, et al. Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol. 1993;138(9):735-45. DOI: https://doi.org/10.1093/oxfordjournals.aje.a116911

Itarat Y, Kietpeerakool C, Jampathong N, Chumworathayi B, Kleebkaow P, Aue-Aungkul A, et al. Sexual behavior and infection with cervical human papillomavirus types 16 and 18. Int J Womens Health. 2019;11:489-94. DOI: https://doi.org/10.2147/IJWH.S218441

Johnson AM, Mercer CH, Beddows S, de Silva N, Desai S, Howell-Jones R, et al. Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain. Sex Transm Infect. 2012;88(3):212-7. DOI: https://doi.org/10.1136/sextrans-2011-050306

Wieland U, Kreuter A, Pfister H. Human papillomavirus and immunosuppression. Curr Probl Dermatol. 2014;45:154-65. DOI: https://doi.org/10.1159/000357907

Nailescu C, Shew ML. Human papillomavirus infection-related cancer risk for kidney transplant recipients during adult life can be reduced by vaccination during childhood and adolescence. Front Pediatr. 2022;10:1057454. DOI: https://doi.org/10.3389/fped.2022.1057454

World Health Organisation. Human papillomavirus vaccines: WHO position paper. 2017. Available at: https://www.who.int/publications/i/item/who-wer9219-241-268. Accessed on 16 May 2025.

Corcoran B, Clarke A, Barrett T. Rapid response to HPV vaccination crisis in Ireland. Lancet. 2018;391(10135):2103. DOI: https://doi.org/10.1016/S0140-6736(18)30854-7

Creed S, Walsh E, Foley T. A qualitative study of parental views of HPV vaccination in Ireland. Eur J Gen Pract. 2021;27(1):1-9. DOI: https://doi.org/10.1080/13814788.2020.1851677

Arksey H, O'malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19-32. DOI: https://doi.org/10.1080/1364557032000119616

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. DOI: https://doi.org/10.1136/bmj.n71

Fahy A, Desmond DM. Irish mothers’ intentions to have daughters receive the HPV vaccine. Irish J Med Sci. 2010;179(3):427-30. DOI: https://doi.org/10.1007/s11845-010-0501-7

McSherry LA, Dombrowski SU, Francis JJ, Murphy J, Martin CM, O'Leary JJ, et al; ATHENS Group. 'It's a can of worms': understanding primary care practitioners' behaviours in relation to HPV using the Theoretical Domains Framework. Implement Sci. 2012;7:73. DOI: https://doi.org/10.1186/1748-5908-7-73

McRae J, Martin C, O'Leary J, Sharp L; Irish Cervical Screening Research Consortium (CERVIVA). "If you can't treat HPV, why test for it?" Women's attitudes to the changing face of cervical cancer prevention: a focus group study. BMC Womens Health. 2014;14:64. DOI: https://doi.org/10.1186/1472-6874-14-64

Migone C, Barrett T, Cotter S, Clarke A, Corcoran B. The Uptake of Human Papillomavirus Vaccine In Irish Schools: The Impact Of Disadvantage. Ir Med J. 2017;110(7):603.

McSherry LA, O'Leary E, Dombrowski SU, Francis JJ, Martin CM, O'Leary JJ, et al; ATHENS (A Trial of HPV Education and Support) Group. Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives. PLoS One. 2018;13(12):e0208482. DOI: https://doi.org/10.1371/journal.pone.0208482

Marshall S, Sahm LJ, Moore AC, Fleming A. A systematic approach to map the adolescent human papillomavirus vaccine decision and identify intervention strategies to address vaccine hesitancy. Public Health. 2019;177:71-9. DOI: https://doi.org/10.1016/j.puhe.2019.07.009

Murphy SJ, Walsh M, Das A. Human papilloma virus and vaccine: knowledge and acceptability in an Irish general hospital-a questionnaire-based study. Ir J Med Sci. 2022;191(2):659-63. DOI: https://doi.org/10.1007/s11845-021-02585-4

Efua Sackey M, Markey K, Grealish A. Healthcare professional's promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review. Vaccine. 2022;40(19):2656-66. DOI: https://doi.org/10.1016/j.vaccine.2022.03.054

Teoh D. The power of social media for HPV vaccination–not fake news! American Society of Clinical Oncology Educational Book. 2019;39:75-8. DOI: https://doi.org/10.1200/EDBK_239363

Sutton S, Azar SS, Evans LK, Murtagh A, McCarthy C, John MS. HPV Knowledge Retention and Concurrent Increase in Vaccination Rates 1.5 Years After a Novel HPV Workshop in Medical School. J Cancer Educ. 2023;38(1):240-7. DOI: https://doi.org/10.1007/s13187-021-02106-y

Theis RP, Wells BA, Staras SAS. "I can be the Judge of What's Serious": A Qualitative Pilot Study of Parents' Responses to Messaging About Side Effects of the HPV Vaccine. Matern Child Health J. 2020;24(4):456-61. DOI: https://doi.org/10.1007/s10995-019-02856-8

Szilagyi PG, Albertin CS, Gurfinkel D, Saville AW, Vangala S, Rice JD, et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine. 2020;38(38):6027-37. DOI: https://doi.org/10.1016/j.vaccine.2020.06.074

Vorsters A, Arbyn M, Baay M, Bosch X, de Sanjosé S, Hanley S, et al. Overcoming barriers in HPV vaccination and screening programs. Papillomavirus Res. 2017;4:45-53. DOI: https://doi.org/10.1016/j.pvr.2017.07.001